Attention Deficit/Hyperactivity Disorder
Exposure to hypertensive disorders of pregnancy may be associated with an increase in the risk for ASD and ADHD in offspring.
While the authors discovered no "sensitive period," the number of stressful events was moderately associated with the severity of attention-deficit/hyperactivity disorder symptoms.
There are considerable gaps in knowledge relating to the effectiveness of nonpharmacologic treatments for ADHD in pediatric patients.
Just as we need to be able to identify who is likely to benefit from treatment, we also need to be able to identify those who are most at risk of experiencing adverse events.
Clinician awareness of this issue is essential in order to continue providing effective treatment while attempting to reduce abuse of these prescription drugs.
Researchers believe that the large increases in clinical ADHD diagnoses were unlikely to be representative of a real bump in prevalence.
These results may mitigate concerns by physicians regarding the pharmacological treatment of individuals with ADHD.
Antipsychotics have been shown to reduce tic severity, as has behavior therapy. However, the mechanisms behind the efficacy of behavior therapy have yet to be clarified by research.
After a median of 25 years of follow-up, 2.4% of those born to a parent with a type 1 diabetes diagnosis were diagnosed with ADHD, compared with only 1.5% of the matched controls.
There is an increase in ADHD medication prescriptions in reproductive-aged women.
Clinical differences may exist between the pharmacological and non-pharmacological treatments commonly used for the management of ADHD.
Children and teens who used stimulants for attention-deficit/hyperactivity disorder had lower bone mineral content and bone density than nonusers.
Patients with comorbid bipolar disorder and ADHD may benefit from methylphenidate treatment, if it can be done without incurring the risk of mania.
Investigators used decomposition methods to examine the relative importance of genetic and environmental components to the burden of ADHD.
These findings are important, as CDC rank alcohol-attributable mortality as the third leading cause of preventable death in the United States.
Investigators developed a test [The Test of Playfulness (ToP)] in order to examine children's play skills in peer-to-peer play interactions.
Neuropsychological findings indicate that similar executive functions are affected in ADHD and OCD, but new neuroimaging data indicate differences exist in brain structure and function.
While there is no cure for ADHD, currently available treatments such as medication, psychotherapy, education, or training can help reduce symptoms and improve functioning.
Children with ADHD may adapt more poorly to changing positive reinforcements compared with typically developing children.
For some people, symptoms of ADHD do not emerge until after childhood.
Study is first to investigate the influence of relative age on ADHD diagnosis and treatment in an Asian country.
Clinicians should realize the potential harm ADHD medications may pose to maturing bones, and consider nutritional counseling.
From 1981 to 1997, time spent teaching 3- to 5-year-olds letters and numbers increased 30%.
Both scales yield moderate sensitivity for diagnosing ADHD in children and adolescents.
Telepsychiatry could help with the major shortage of psychiatrists in the US.
Findings are contrary to suggestions that the most severe misuse of Adderall is among older children.
Although not usually considered as part of primary treatment, nutrition addresses the crucial link between food and brain functioning.
Preemies may possess elevated levels of characteristics that put them at risk for peer victimization, including more anxiety and depression.
The risk increased with longer follow-up, was greater in males and was particularly associated with olanzapine.
Lumos Labs, the creators of Lumosity, will pay $2 million to settle Federal Trade Commission charges.
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Should Physicians Treat Family and Friends? Three Experts Weigh In
- Transference in the Age of #MeToo: What Counts as Harassment From a Patient?
- Dialectical Behavior Therapy Effective in Reducing Suicide Attempts, Self-Harm in Adolescents
- Influence of Psychostimulants on BMI and Height in Youth With ADHD
- Medication Adherence Predictors in Patients With Severe Psychiatric Disorders
- Court-Mandated Substance Abuse Treatment: Exploring the Ethics and Efficacy
- ADHD Treatments
- Esketamine Nasal Spray: A New Treatment Possibility for Treatment-Resistant Depression
- Pharmacogenetics in Psychiatry: Promising Developments and Potential Pitfalls
- Substance Abuse and Primary Psychosis: A Closer Look
- Functional Restoration for Chronic Pain and Depression in the Elderly: Pharmacotherapy and Beyond
- Efficacy of Long-Acting Injectable Antipsychotics vs Oral Antipsychotics
- Older Age Associated With Worse Major Depressive Disorder Outcomes
- Preoperative Psychiatric Diagnoses Not Associated With Bariatric Surgery Outcomes
- Medical Clearance of Psych Patients in the ED: Consensus Recommendations